跳至主要内容
临床试验/NCT03355846
NCT03355846已完成4 期

Pain and Bleeding in Subjects With Acute Anal Fissure: Comparative Evaluation of Three Treatments

University of Roma La Sapienza1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2018年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
99
试验地点
1
主要终点
time for the disappearance of pain

研究概览

简要总结

Starting from the observation that acute anal fissure (AAF) in 6-8 weeks can heal spontaneously and that some of the commonly used commercial products in clinical practice would seem to be useful, the rationale of the comparative study is to try to identify, in compliance with the protocol of Helsinki (2013), the most effective short-term treatment for the disappearance of pain in defecation and cessation of bleeding, shortening the duration of the healing process and favoring the patient's rapid return to his / her activity, respect for patient safety.

详细描述

Starting from the observation that anal fissure in 6-8 weeks can heal spontaneously and that some of the commonly used commercial products in clinical practice would seem to be useful, the rationale of the comparative study is to try to identify, in compliance with the protocol of Helsinki (2013), the most effective short-term treatment for the disappearance of pain in defecation and cessation of bleeding, shortening the duration of the healing process and favoring the patient's rapid return to his / her activity, respect for patient safety.

The comparative study will be conducted by comparing the following products:

  • Centella® Complex 1 cps 60 mg per os after meals twice a day for 15 days;
  • Proctocella® Complex cream to be applied in anal area and anal canal after hygiene treatment for 4 weeks;
  • Flavonil® 1 cps 300 mg per os after meals twice a day for 15 days;
  • Flavonil® Cream Cream to be applied in anal region and anal canal after hygiene treatment for 4 weeks;
  • Rectalgan Mousse cleansing cleanser for anal and perineal region for 4 weeks.

Our approach attempts to blend, based on the evidence of the most recent scientific literature, the experience of decades of colonproctologic clinical practice that has a predominantly surgical approach, with the clinical evidence of the Science of Nutrition which has a conservative vision in the treatment of ailments and constipation, a predisposing factor in the pathogenesis of anal fissure, in order to obtain healing without surgery. The control group will receive the traditional basic treatment consisting in the application of lubricated anal dilators of increasing gauge according to predetermined pattern, hygiene and diet. The two groups with which they will be compared for the results will receive, in addition to the foregoing (for controls), or Flavonoids (ProtFlav) or Asian Centella Extract (ProtCent), in the form of local mouth and cream tablets to be applied at the perianal level and possibly in the anal canal with gloved finger, containing the same active principles also administered by mouth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects With Acute Anal Fissure
  • Collaborative patients able to understand and want;

排除标准

  • Pregnancy

研究组 & 干预措施

AAF treated with Centella® Complex

Experimental

Centella® Complex 1 cps 60 mg per os

干预措施: Centella (Drug)

AAF treated with Proctocella® cream

Experimental

Proctocella® Complex cream to be applied in anal area and anal canal

干预措施: Proctocella (Drug)

AAF treated with Flavonil® cps

Experimental

Flavonil® 1 cps 300 mg per os

干预措施: Flavonil® cps (Drug)

AAF treated with Flavonil® Cream

Experimental

Flavonil® Cream Cream to be applied in anal region and anal canal

干预措施: Flavonil® Cream (Drug)

AAF treated with Rectalgan Mousse

Experimental

Rectalgan Mousse cleansing cleanser for anal and perineal region

干预措施: Rectalgan Mousse (Drug)

结局指标

主要结局

time for the disappearance of pain

时间窗: 1 month

time for the disappearance of pain in course of treatment

次要结局

  • time for the disappearance of bleeding(1 month)

研究者

发起方
University of Roma La Sapienza
申办方类型
Other
责任方
Principal Investigator
主要研究者

Massimo Chiaretti

Reasercher

University of Roma La Sapienza

研究点 (1)

Loading locations...

相似试验